ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Torrent Pharmaceuticals filed a security cover certificate for its non-convertible debentures. The certificate confirms a standalone security cover of 0.33 times book value.
Torrent Pharmaceuticals is valuing key brands at Rs. 16,374.09 Crore to raise funds via NCDs. The valuation includes brands like Nexpro, Chymoral, Rozucor, and Veloz.
Torrent Pharmaceuticals Limited filed its security cover certificate for outstanding NCDs totaling ₹11,156.14 Crore. The filing confirms adequate asset coverage as of March 2026.
Torrent Pharmaceuticals Limited submitted details of four listed Non-Convertible Debentures (NCDs) totalling ₹11,000 Crore issued via private placement. The company also confirmed the redemption of NCDs (ISIN INE685A07082) on December 12, 2025. This filing maintains regulatory compliance regarding debt security disclosures for the half-year ended March 31, 2026.
Torrent Pharmaceuticals Limited confirmed the full utilization of proceeds from its issued Commercial Papers for the quarter ending March 31, 2026. This filing adheres to SEBI Master Circular requirements regarding debt instruments.